SINGULAIR is a prescription medicine approved to help control symptoms of asthma in adults and children 12 months and older and for relief of symptoms of indoor and outdoor allergies (outdoor allergies in adults and children as young as 2 years and indoor allergies in adults and children as young as 6 months).
IMPORTANT SAFETY INFORMATION: SINGULAIR is not a rescue medication. Always carry your child’s prescribed rescue inhaler for emergencies or sudden symptoms. If asthma symptoms get worse or your child needs to increase the use of fast-acting medicines, call the doctor at once. Side effects are generally mild and vary by age, and may include headache, ear infection, sore throat, and upper respiratory infection.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please read the Patient Information and discuss it with your doctor. The physician Prescribing Information also is available.
This site is intended only for residents of the United States, its territories, and Puerto Rico.
SINGULAIR is a registered trademark of Merck & Co., Inc.
20851330(2)-09/08-SNG
